US Patent Issued to FORMA Therapeutics on April 15 for "Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors" (Massachusetts, Connecticut Inventors)

ALEXANDRIA, Va., June 5 -- United States Patent no. 12,275,715, issued on April 15, was assigned to FORMA Therapeutics Inc. (Watertown, Mass.).

"Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors" was invented by Jian Lin (Acton, Mass.), Anna Ericsson (Shrewsbury, Mass.), Ann-Marie Campbell (Monroe, Conn.), Gary Gustafson (Ridgefield, Conn.), Zhongguo Wang (Lexington, Mass.), R. Bruce Diebold (Waltham, Mass.), Susan Ashwell (Carlisle, Mass.), David R. Lancia Jr. (Boston), Justin Andrew Caravella (Cambridge, Mass.) and Wei Lu (Newton, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) protein...